{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:19:08Z","timestamp":1761293948678,"version":"3.44.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013088","name":"Qinglan Project of Jiangsu Province of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013088","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.bioorg.2019.103083","type":"journal-article","created":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T08:16:52Z","timestamp":1561105012000},"page":"103083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Discovery of aromatic amides with triazole-core as potent reversal agents against P-glycoprotein-mediated multidrug resistance"],"prefix":"10.1016","volume":"90","author":[{"given":"Qianqian","family":"Qiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jilan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiutong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziqian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueting","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenlong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongquan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bioorg.2019.103083_b0005","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0928-0987(00)00114-7","article-title":"Multidrug resistance (MDR) in cancer","volume":"11","author":"Krishna","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2019.103083_b0010","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.ejmech.2015.06.049","article-title":"Reversal of P-gp and BCRP-mediated MDR by tariquidar derivatives","volume":"101","author":"Li","year":"2015","journal-title":"Eur. J. Med. Chem."},{"year":"2007","series-title":"Identification of Molecular Determinants of Tumor Sensitivity and Resistance to Anticancer Drugs","author":"Quintieri","key":"10.1016\/j.bioorg.2019.103083_b0015"},{"key":"10.1016\/j.bioorg.2019.103083_b0020","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejmech.2017.07.033","article-title":"Recent advances (2015\u20132016) in anticancer hybrids","volume":"142","author":"Kerru","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2019.103083_b0025","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.canlet.2015.10.010","article-title":"Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: a review of the past decade","volume":"370","author":"Chen","year":"2016","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2019.103083_b0030","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0005-2736(76)90160-7","article-title":"A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants","volume":"455","author":"Juliano","year":"1976","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.bioorg.2019.103083_b0035","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1124\/dmd.113.056176","article-title":"Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy?","volume":"42","author":"Callaghan","year":"2014","journal-title":"Drug. Metab. Dispos."},{"issue":"13","key":"10.1016\/j.bioorg.2019.103083_b0040","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.2174\/092986712800167392","article-title":"Three decades of P-gp inhibitors: skimming through several generations and scaffolds","volume":"19","author":"Palmeira","year":"2012","journal-title":"Curr. Med. Chem."},{"issue":"14","key":"10.1016\/j.bioorg.2019.103083_b0045","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1039\/C5OB00233H","article-title":"3-(Benzo[d][1,3]dioxol-5-ylamino)-N-(4-fluorophenyl)thiophene-2-carboxamide overcomes cancer chemoresistance via inhibition of angiogenesis and P-glycoprotein efflux pump activity","volume":"13","author":"Mudududdla","year":"2015","journal-title":"Org. Biomol. Chem."},{"issue":"19","key":"10.1016\/j.bioorg.2019.103083_b0050","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.1039\/C5OB00554J","article-title":"Synthesis and P-glycoprotein induction activity of colupulone analogs","volume":"13","author":"Bharate","year":"2015","journal-title":"Org. Biomol. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2019.103083_b0055","first-page":"1967","article-title":"Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil","volume":"41","author":"Tsuruo","year":"1981","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2019.103083_b0060","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.drup.2016.05.001","article-title":"Overcoming ABC transporter-mediated multidrug resistance: molecular mechanisms and novel therapeutic drug strategies","volume":"27","author":"Li","year":"2016","journal-title":"Drug Resist. Update"},{"issue":"2","key":"10.1016\/j.bioorg.2019.103083_b0065","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/ijc.21827","article-title":"In vitro and in vivo evaluation of WK-X-34, a novel inhibitor of P-glycoprotein and BCRP, using radio imaging techniques","volume":"119","author":"Jekerle","year":"2010","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.bioorg.2019.103083_b0070","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.clinthera.2012.01.003","article-title":"Tolerability and pharmacokinetics of a new P-glycoprotein inhibitor, HM30181, in healthy Korean male volunteers: single- and multiple-dose randomized, placebo-controlled studies","volume":"34","author":"Kim","year":"2012","journal-title":"Clin. Ther."},{"issue":"4","key":"10.1016\/j.bioorg.2019.103083_b0075","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.ejmech.2014.11.001","article-title":"Deconstruction of 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline moiety to separate P-glycoprotein (P-gp) activity from \u03c3 2 receptor affinity in mixed P-gp\/\u03c3 2 receptor agents","volume":"89","author":"Pati","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2019.103083_b0080","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2174\/15680096113139990076","article-title":"P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives","volume":"13","author":"Binkhathlan","year":"2013","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.bioorg.2019.103083_b0085","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fonc.2014.00041","article-title":"Complex interplay between the P-glycoprotein multidrug efflux pump and the membrane: its role in modulating protein function","volume":"4","author":"Sharom","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bioorg.2019.103083_b0090","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ejmech.2016.09.070","article-title":"Extending the structure-activity relationship study of marine natural ningalin B analogues as P-glycoprotein inhibitors","volume":"125","author":"Yang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103083_b0095","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ejmech.2016.08.044","article-title":"Structure\u2212activity relationship study of novel 2-Aminobenzofuran derivatives as P-glycoprotein inhibitors","volume":"125","author":"Chen","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2019.103083_b0100","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1016\/j.bmc.2007.11.057","article-title":"Functional assay and structure-activity relationships of new third-generation P-glycoprotein inhibitors","volume":"16","author":"M\u00fcller","year":"2008","journal-title":"Bioorg. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2019.103083_b0105","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ejmech.2014.02.051","article-title":"SAR study on arylmethyloxyphenyl scaffold: looking for a P-gp nanomolar affinity","volume":"76","author":"Nesi","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2019.103083_b0110","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1021\/acs.jmedchem.6b01787","article-title":"Design, synthesis, and pharmacological characterization of N-(4-(2 (6, 7-dimethoxy-3, 4-dihydroisoquinolin-2 (1 h) yl) ethyl) phenyl) quinazolin-4-amine derivatives: novel inhibitors reversing P-glycoprotein-mediated multidrug resistance","volume":"60","author":"Qiu","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103083_b0115","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bioorg.2017.01.010","article-title":"Medicinal attributes of 1,2,3-triazoles: current developments","volume":"71","author":"Dheer","year":"2017","journal-title":"Bioorg. Chem."},{"issue":"50","key":"10.1016\/j.bioorg.2019.103083_b0120","doi-asserted-by":"crossref","first-page":"11844","DOI":"10.1002\/anie.201105707","article-title":"Click chemistry finds its way into covalent porous organic materials","volume":"50","author":"Muller","year":"2011","journal-title":"Angew. Chem. Int. Edit."},{"issue":"4","key":"10.1016\/j.bioorg.2019.103083_b0125","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1021\/ar200235m","article-title":"Click dendrimers and triazole-related aspects: catalysts, mechanism, synthesis, and functions. A bridge between dendritic architectures and nanomaterials","volume":"45","author":"Astruc","year":"2012","journal-title":"Acc. Chem. Res."},{"issue":"1","key":"10.1016\/j.bioorg.2019.103083_b0130","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1042\/bse0500161","article-title":"The P-glycoprotein multidrug transporter","volume":"50","author":"Sharom","year":"2011","journal-title":"Essays Biochem."},{"key":"10.1016\/j.bioorg.2019.103083_b0135","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ejmech.2016.07.050","article-title":"Aromatic heterocyclic esters of podophyllotoxin exert anti-MDR activity in human leukemia K562\/ADR cells via ROS\/MAPK signaling pathways","volume":"123","author":"Zhang","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2019.103083_b0140","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1039\/c3gc37004f","article-title":"\u201cAll-water\u201d one-pot diverse synthesis of 1, 2-disubstituted benzimidazoles: hydrogen bond driven \u2018synergistic electrophile\u2013nucleophile dual activation\u2019by water","volume":"15","author":"Kommi","year":"2013","journal-title":"Green Chem."},{"issue":"36","key":"10.1016\/j.bioorg.2019.103083_b0145","doi-asserted-by":"crossref","first-page":"9373","DOI":"10.1039\/C5OB01532D","article-title":"Synthesis of quinoxalines or quinolin-8-amines from N-propargyl aniline derivatives employing tin and indium chlorides","volume":"13","author":"Aichhorn","year":"2015","journal-title":"Org. Biomol. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2019.103083_b0150","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/cbdd.12301","article-title":"Discovery of novel P-glycoprotein-mediated multidrug resistance inhibitors bearing triazole core via click chemistry","volume":"84","author":"Liu","year":"2014","journal-title":"Chem. Biol. Drug. Des."},{"issue":"24","key":"10.1016\/j.bioorg.2019.103083_b0155","doi-asserted-by":"crossref","first-page":"6857","DOI":"10.1016\/j.bmc.2014.10.032","article-title":"Design, synthesis and evaluation of novel triazole core based P-glycoprotein-mediated multidrug resistance reversal agents","volume":"22","author":"Jiao","year":"2014","journal-title":"Bioorg. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2019.103083_b0160","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1021\/jm201121b","article-title":"Amine linked flavonoid dimers as modulators for P-glycoprotein-based multidrug resistance: structure-activity relationship and mechanism of modulation","volume":"55","author":"Chan","year":"2012","journal-title":"J. Med. Chem."},{"issue":"6441","key":"10.1016\/j.bioorg.2019.103083_b0165","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.aav9406","article-title":"RK2, H.S. Mchaourab, Mechanism of allosteric modulation of P-glycoprotein by transport substrates and inhibitors","volume":"364","author":"Dastvan","year":"2019","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.bioorg.2019.103083_b0170","first-page":"749","article-title":"In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576","volume":"61","author":"Mistry","year":"2001","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bioorg.2019.103083_b0175","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/cmdc.201402463","article-title":"6,7 Dimethoxy 2 2 [4 (1H 1,2,3 triazol 1 yl)phenyl]ethyl 1,2,3,4 tetrahydroisoquinolines as superior reversal agents for P glycoprotein mediated multidrug resistance","volume":"10","author":"Liu","year":"2015","journal-title":"Chemmedchem"},{"issue":"1","key":"10.1016\/j.bioorg.2019.103083_b0180","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejps.2010.05.016","article-title":"Differences in assessment of macrolide interaction with human MDR1 (ABCB1, P-gp) using rhodamine-123 efflux, ATPase activity and cellular accumulation assays","volume":"41","author":"Munic","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.bioorg.2019.103083_b0185","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1023\/A:1025092829696","article-title":"Rapid assessment of P-glycoprotein inhibition and induction in vitro","volume":"20","author":"Perloff","year":"2003","journal-title":"Pharm. Res."},{"issue":"11","key":"10.1016\/j.bioorg.2019.103083_b0190","first-page":"2952","article-title":"Effect of alpha-interferon on P-glycoprotein expression and function and on verapamil modulation of doxorubicin resistance","volume":"54","author":"Kang","year":"1994","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.bioorg.2019.103083_b0195","doi-asserted-by":"crossref","first-page":"762","DOI":"10.2174\/138920010794328922","article-title":"Predicting drug-drug interactions involving the inhibition of intestinal CYP3A4 and P-glycoprotein","volume":"11","author":"Tachibana","year":"2010","journal-title":"Curr. Drug Metab."},{"issue":"4","key":"10.1016\/j.bioorg.2019.103083_b0200","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/bjc.1989.306","article-title":"The MTT assay underestimates the growth inhibitory effects of interferons","volume":"60","author":"Jabbar","year":"1989","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.bioorg.2019.103083_b0205","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0959-8049(01)00356-2","article-title":"The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7\/adr cells","volume":"38","author":"Fu","year":"2002","journal-title":"Eur. J. Cancer"},{"issue":"9","key":"10.1016\/j.bioorg.2019.103083_b0210","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.7314\/APJCP.2013.14.9.4983","article-title":"Mechanistic analysis of taxol-induced multidrug resistance in an ovarian cancer cell Line","volume":"14","author":"Ning-Ning","year":"2013","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"17","key":"10.1016\/j.bioorg.2019.103083_b0215","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1021\/jm900194w","article-title":"Modulation of multidrug resistance protein 1 (MRP1\/ABCC1)-mediated multidrug resistance by bivalent apigenin homodimers and their derivatives","volume":"52","author":"Wong","year":"2009","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2019.103083_b0220","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/0959-8049(94)90187-2","article-title":"A comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypes","volume":"30A","author":"Twentyman","year":"1994","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"10.1016\/j.bioorg.2019.103083_b0225","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bcp.2014.06.006","article-title":"Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1","volume":"90","author":"Wang","year":"2014","journal-title":"Biochem. Pharmacol."},{"issue":"s 1\u20132","key":"10.1016\/j.bioorg.2019.103083_b0230","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantization of microgram quantities of protein utilizing the principle of protein dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"issue":"5","key":"10.1016\/j.bioorg.2019.103083_b0235","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1742-7843.2008.00227.x","article-title":"In vitro inhibition of CYP3A4 metabolism and P-glycoprotein-mediated transport by trade herbal products","volume":"102","author":"Hellum","year":"2010","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"5","key":"10.1016\/j.bioorg.2019.103083_b0240","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00280-007-0420-0","article-title":"Tetrandrine achieved plasma concentrations capable of reversing MDR in vitro and had no apparent effect on doxorubicin pharmacokinetics in mice","volume":"60","author":"Dai","year":"2007","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"3","key":"10.1016\/j.bioorg.2019.103083_b0245","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0022-3565(24)29199-0","article-title":"Identification of variants of CYP3A4 and characterization of their abilities to metabolize testosterone and chlorpyrifos","volume":"299","author":"Dai","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819306376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819306376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:53:11Z","timestamp":1758613991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206819306376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":49,"alternative-id":["S0045206819306376"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.103083","relation":{},"ISSN":["0045-2068"],"issn-type":[{"type":"print","value":"0045-2068"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of aromatic amides with triazole-core as potent reversal agents against P-glycoprotein-mediated multidrug resistance","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.103083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103083"}}